BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34606488)

  • 1. Distinguishing Meningioma From Metastasis of Prostate Cancer on 68Ga-PSMA PET/CT.
    Filizoglu N; Oksuzoglu K; Ozguven S
    Clin Nucl Med; 2021 Nov; 46(11):e553-e555. PubMed ID: 34606488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.
    Bilgin R; Ergül N; Çermik TF
    Clin Nucl Med; 2016 Dec; 41(12):956-958. PubMed ID: 27824323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
    Kesim S; Oksuzoglu K
    Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.
    Zang S; Shao G; Cui C; Li TN; Huang Y; Yao X; Fan Q; Chen Z; Du J; Jia R; Sun H; Hua Z; Tang J; Wang F
    Oncotarget; 2017 Feb; 8(7):12247-12258. PubMed ID: 28103574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid Incidentaloma on 68Ga-PSMA-11 PET/CT Leading to Detection of Thyroid Metastasis in Metastatic Prostate Carcinoma.
    Parghane RV; Basu S
    Clin Nucl Med; 2022 Mar; 47(3):e300-e301. PubMed ID: 34690291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental Meningioma With Altered PSMA Expression After Systemic Hormone Therapy and Local Radiotherapy Detected by 68 Ga-PSMA PET/CT.
    Tamer F; Omur O
    Clin Nucl Med; 2023 Jun; 48(6):507-509. PubMed ID: 37019127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia.
    Santhosh S; Jeeva G
    Clin Nucl Med; 2021 Apr; 46(4):e190-e192. PubMed ID: 33234940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Singh B; Sharma S; Bansal P; Hooda M; Singh H; Parihar AS; Kumar A; Watts A; Mohan R; Singh SK
    Nucl Med Commun; 2021 May; 42(5):482-489. PubMed ID: 33395191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Case of Small Cell Metastatic Prostatic Adenocarcinoma, Properly Staged by 68Ga-PSMA PET/CT Scan.
    Golestani ZB; Soltani S; Kalantari MR; Ghorbani HR; Aghaee A
    Clin Nucl Med; 2022 Mar; 47(3):e259-e261. PubMed ID: 35025791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary Femoral Nodal Metastasis Identified With 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Hilliar L; Yip JWL; Wong VCK; Le K; Mansberg R
    Clin Nucl Med; 2021 Feb; 46(2):173-174. PubMed ID: 33315675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis.
    Hu X; Wu Y; Yang P; Wang J; Wang P; Cai J
    Int Braz J Urol; 2022; 48(6):891-902. PubMed ID: 34003611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meta-analysis of the effect of 68Ga-PSMA-PET/CT diagnosis of prostatic cancer compared with bone scan.
    Zhao R; Li Y; Nie L; Qin K; Zhang H; Shi H
    Medicine (Baltimore); 2021 Apr; 100(15):e25417. PubMed ID: 33847640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-PSMA-11 PET/CT in Isolated Bilateral Adrenal Metastases From Prostate Adenocarcinoma.
    Zhao Q; Yang B; Dong A; Zuo C
    Clin Nucl Med; 2022 Jan; 47(1):e101-e102. PubMed ID: 34115707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
    Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
    Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary lymph-node staging with
    Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
    Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
    Stanzel S; Weitzer F; Janek E; Plhak E; Aigner RM
    Clin Nucl Med; 2023 Dec; 48(12):1064-1065. PubMed ID: 37934704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient.
    Xu G; Lu Y
    Clin Nucl Med; 2021 Aug; 46(8):675-676. PubMed ID: 33577202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
    Rosar F; Bartholomä M; Maus S; Privé BM; Khreish F; Franssen GM; Derks YHW; Nagarajah J; Ezziddin S
    Clin Nucl Med; 2022 May; 47(5):435-436. PubMed ID: 35234197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.